TOFACITINIB
Generic: TOFACITINIB
Aurobindo Pharma LimitedManufacturer
ORALRoute
TOFACITINIB CITRATEActive Substance
2024-06-03Original Approval
TOFACITINIB is FDA application ANDA218462, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
5,216 reports
2
RHEUMATOID ARTHRITIS
3,950 reports
3
OFF LABEL USE
3,888 reports
4
PAIN
3,589 reports
5
DRUG INTOLERANCE
3,505 reports
6
FATIGUE
3,404 reports
7
RASH
3,379 reports
8
JOINT SWELLING
3,264 reports
9
SYNOVITIS
3,105 reports
10
SYSTEMIC LUPUS ERYTHEMATOSUS
3,032 reports